$HIPH CEO Transcript interview with American Premium Water

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
173
$HIPH CEO Transcript interview with American Premium Water Corporation (OTC:HIPH) CEO Ryan Fishoff.



The Company recently announced that all preorders had been filled. Are your Companys products available for sale now?



The Company has products available for sale on the CaliBear website (www.calibearlife.com). CaliBear CBD products are in the process of being sent to retailers over the coming weeks. I recently posted on my personal twitter account last friday about one smokeship in particular that we brought online. Stores are being added and we look to add more. We are focusing our efforts towards wholesale and retails distribution while simultaneously incorporating digital advertising to grow our online business. Our number one priority is to grow sales and incrase revenue.



The CBD industry has been oversatured over the past year. How is the Companys new brand standing out?



Just because there has been quantity, does not mean there is quality. I would estimate that 75-80% of the brands are just slapping CBD on the label hoping for a quick buck. We have been at this for a while. We have superior, quality products that are effective and manufactured to FDA and GMP practices. Another aspect that I believe differentes CaliBear from our competitors is the Companys partnership with the AVP, which has been a game changer. It's one of the first CBD partnerships with a major league sports league. Most importantly, it gives CaliBear credibility with consumers and retailers. It's a validation of the product that its major league quality, which I feel puts us on a pedestal in the eyes of consumers. It's been a great partnership so far, one that we are fortunate to have. We are looking to further expand our partnership with the AVP while looking at innovative partnerships in the sports world, including looking to return to the Super Bowl next year, which will be held in Los Angeles.



Can you give an overview of CaliBear CBD brand?



The Company entered into a JV agreement with CaliBear back in February to produce an entire line of CBD products that includes CBD infused gummies, CBD tinctures, CBD pain cream, CBD lip balm, and CBD infused nano water and shots. The brand is performance lifestyle that looks to incorporate the California lifestyle of with premium CBD products that help promote performance and relaxation. Beach volleyball encapsulates this relationship very well, which is why we partnered with the AVP, where CaliBear has 8 active players as part of Team CaliBear. These players act as great ambassadors of the brand, and provide great visibility for the product along with the sponsorship with the AVP.



While the brand has a California influence, it seems your Companys focus is on the New York region. Any specific reason for that?


Well I am based here, so it is convenient! All kidding aside, there is a strategic reason for our focus on the New York tri-state area. Legalization in New York, New Jersey, and Connecticut have occurred within the past year. CBD culture and consumer education is not very high in the region. It's a relatively new type of product that, whether correctly or incorrectly because of the cannabis legalization, is on the radar now of stores and consumers. The Company acquired Hemp cannabinoid licenses in New York state for distribution and retail. I believe this is a very valuable resource that will allow the Company to come up with innovative installation and activation programs to promote and sell CaliBear and other CBD products. There is going to be greater adoption of it in this region. I think this gives us a tremendous opportunity to get real estate and establish our brand in the area and beyond. In the I-95 corridor between Maine and Virginia, there are approximately as many people as California in a space half the size. The population density along with being situated with some of the countrys largest cities is a tremendous opportunity.



Your Company name (American Premium Water Corporation) has water in it, yet you do not have any water or beverage products available. When will the Company be selling any water infused products?



Its been frustrating for me as well, as nanotechnology with water has been our primary focus over the past couple of years. What has caused the delay in launch has been perfecting the flavor profile of the product. We are in the final stages of testing and development and look forward to bringing to market as soon as possible. I anticipate having an update on the launch of the CBD nano water and CBD nano shots later this quarter. These products have received a tremendous amount of inquiries; I think there is tremendous demand in the market for effective CBD waters. The nanotechnology allows the CBD to permeate into the bloodstream more effectively than regular CBD beverages. When all is said and done, I think the beverages (both water and shots) will be our most popular CBD product, which will open more retail doors for us.



Are there any other products that utilize nanotechnology in the pipeline?



I have been a big believer in nano-technology and its efficacy of amplifying compounds for many years. I really believe in the power of the technology to be a game changer in delivering a compound into the bloodstream in a more efficient manner. Beyond CBD, I believe there are a number of clinical and therapeutic applications of the technology. We are currently working on developing products that can utilize this groundbreaking technology, but also leverage the Companys existing distribution network. We are currently experimenting with a couple of compounds, nitrous oxide being one of them, which the Company has mentioned in public releases over the past year.



The Company did mention nitrous oxide beverages when it announced the product being sent to Asia as part of its relationship with BioHealth Water. Are you still working with them?



BioHealth Water is a minority shareholder in the Company, and management has continued to lean on them for guidance over the past year. We are working with them to create CBD and non-CBD products to place in their global distribution networks. In addition we are working with them to retain a PCAOB auditing firm to complete a two year audit to become fully reporting. That has been a long term goal of mine and I hope to have an update about next steps of the audit in the next couple of months. Best case scenario, it will be completely by the 1st half of next year.



Safe Harbor Notice

Certain statements contained herein are forward-looking statements (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC" EDGAR database.



This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate", "project", "intend", "forecast", "anticipate", "plan", "planning", "expect", "believe", "will likely", "should", "could", "would", "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, and domestic or global economic conditions -- activities of competitors and the presence of new or additional competition and conditions of equity markets.



This press release is issued on behalf of the Board of Directors of American Premium Water Corporation.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 446

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 333

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 38

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 90

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 104

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

SOCi's AI Marketing: Leading G2's Summer 2026 Rankings

Updated Category News Views 12

AI's Rising Star in Enterprise Marketing Here's a tidbit worth chewing over your morning coffee: SOCi Inc., a name that's been buzzing in the enterprise circles, has nailed top spots in G2's Summer 2026 Report. We're talking about leading the charge in AI marketing and localized visibility, territories tough to crack unless you've got serious chops. In a world where...

Continue Reading
AI and the Future of Staffing: A Market Growth Story

Updated Category News Views 344

AI and the Future of Staffing: A Growth Story The staffing services market is on the verge of a major transformation, thanks in large part to advancements in Artificial Intelligence (AI). This evolution is projected to add an astounding USD 236.6 billion to the global staffing services market between 2024 and 2028. During this time, the market is expected to experience a...

Continue Reading
Optical Innovations Unite: OCC and Lightera's New Partnership

Updated Category News Views 317

Strategic Collaboration Between OCC and Lightera Optical Cable Corporation (NASDAQ: OCC) and Lightera, LLC are entering a significant partnership aimed at enhancing their product offerings primarily in the data center and enterprise sectors. This collaboration builds upon their long-term relationship, combining their strengths to create innovative optical connectivity...

Continue Reading
INFINOX Welcomes Artem Gonov as New Chief Technology Officer

Updated Category News Views 148

INFINOX Appoints Artem Gonov as Chief Technology Officer INFINOX, a globally recognized brokerage, has recently appointed Artem Gonov as its new Chief Technology Officer (CTO). This strategic move underlines the company's commitment to enhancing its technology landscape and providing exceptional platforms for its clients. Artem Gonov's Background and Expertise Mr. Gonov...

Continue Reading
George Medicines’ GMRx2 Sets New Standard for Hypertension Care

Updated Category News Views 126

George Medicines Introduces GMRx2 for Hypertension Management Recent findings published in The Lancet highlighted the promising results of a Phase III trial for GMRx2, a novel triple combination pill aimed at managing hypertension. Developed by George Medicines, this medication is making waves in the field of cardiovascular care as it demonstrates significant advancements...

Continue Reading